Boehringer Ingelheim SComm SComm
109.2 FTEThe score of Boehringer Ingelheim SComm shows with a free account.
See the score- Summary? / 5
- Solvency
- Liquidity
- Interest coverage
- Profitability
- Leverage
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +47 % Equity +96 % Total assets +14 % Headcount (avg FTE) -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Boehringer Ingelheim SComm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €164.7m | ||||
| Net result | €43.0m | ||||
| Equity | €1.54bn | ||||
| Cash | 191,292 € | ||||
| EBITDA | €10.4m | ||||
| Total assets | €1.60bn |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 02 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
Boehringer Ingelheim SComm's financial analysis
- Solvency96.2%sector median: 36.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Boehringer Ingelheim SComm
Boehringer Ingelheim SComm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0435.953.632
- VAT number
- BE0435953632
- Peppol
- Registered · 0208:0435953632 · as of 10 Oct 2026
- Legal form
- SComm
- Incorporated
- 30 Nov 1988
- Registered office
- 1050 Ixelles
- Size
- Medium · 109.2 FTE
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Boehringer Ingelheim SComm (SComm) has been based in Ixelles since 1988, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €164.7m, a net profit of €43.0m and equity of €1.54bn. With 109.2 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 96.2%, above the median of its sector (36.0%).
Companies similar to Boehringer Ingelheim SComm
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- SERB1050 Ixelles
- MSD Belgium1170 Watermael-Boitsfort
- Bristol - Myers Squibb Belgium1170 Watermael-Boitsfort
- Centre Europeen DE Repartition Pharmaceutique1070 Anderlecht
- EG1020 Brussels
- Besins Healthcare1050 Ixelles
- Medtronic Belgium1090 Jette
- UPSA Belgium1040 Etterbeek
Frequently asked questions about Boehringer Ingelheim SComm
What is the revenue of Boehringer Ingelheim SComm?
According to the 2025 annual accounts filed with the NBB, the revenue of Boehringer Ingelheim SComm amounts to 164,690,516 €.
What is the VAT number of Boehringer Ingelheim SComm?
In Belgium, the VAT number is the company number prefixed with BE: BE0435953632 for Boehringer Ingelheim SComm, if the company is VAT-registered. Its company number (CBE) is 0435.953.632.
Where is the registered office of Boehringer Ingelheim SComm?
According to the CBE register, the registered office of Boehringer Ingelheim SComm is in 1050 Ixelles.
What is the equity of Boehringer Ingelheim SComm?
At the close of the 2025 financial year, the equity of Boehringer Ingelheim SComm amounts to 1,537,702,789 €, a solvency of 96.2% of total assets.
How many people work at Boehringer Ingelheim SComm?
109.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Boehringer Ingelheim SComm?
The register lists 3 active mandates at Boehringer Ingelheim SComm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Boehringer Ingelheim SComm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →